Search for: "ABBOTT v. WYETH" Results 61 - 80 of 111
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2010, 10:28 pm
(Patent Docs) Trilipix (Fenofibrate) - US: Patent infringement complaint following a Para IV certification: Abbott Laboratories et al. v. [read post]
27 May 2010, 3:20 am
(Spicy IP) Trilipix (Fenofibrate) – US: Patent infringement complaint following Paragraph IV challenge: Abbott Laboratories et al. v. [read post]
13 May 2010, 4:58 pm
(Patent Docs)   Products Alavert (Loratadine) – US: TTAB vacates WAL-VERT decision per District Court order: Wyeth v Walgreen Co (not precedential) (TTABlog) Axid (Nizatidine), Synthanthic (Oxfendazole) – US: False marking complaint: Baker v. [read post]
13 May 2010, 12:27 pm by Bexis
Wyeth, Inc., 2010 WL 450351 (W.D. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’:… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’:… [read post]
11 Dec 2009, 5:00 am
Wyeth, Inc., 85 Cal.Rptr.3d 299 (Cal. [read post]
17 Sep 2009, 4:30 am
Given the size of the overdose, no alleged illegibility of the little lines on the cup could possibly have made the slightest difference in the result.What's going on in those cases is the same thing we've already commented about in the context of the big preemption cases, Wyeth v. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of… [read post]